Publication | Closed Access

Leukemogenic Risk of Hydroxyurea Therapy as a Single Agent in Polycythemia Vera and Essential Thrombocythemia: N-and K-ras Mutations and Microsatellite Instability in Chromosomes 5 and 7 in 69 Patients

Hematological MalignancyPolycythemia VeraMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyMyeloid NeoplasiaPathologyHydroxyurea TherapyOncologyRadiation OncologyLeukemogenic RiskHealth Sciences